Heron Therapeutics
HRTX
#10087
Rank
C$99.32 M
Marketcap
C$0.52
Share price
26.48%
Change (1 day)
-66.44%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): C-$1.58

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is C-$0.27. In 2022 the company made an earnings per share (EPS) of C-$2.44 an increase over its 2021 EPS that were of C-$3.18.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$1.58-35.19%
2022C-$2.44-23.11%
2021C-$3.18-10%
2020C-$3.53-0%
2019C-$3.531.21%
2018C-$3.49-32.7%
2017C-$5.18-19.34%
2016C-$6.4254.76%
2015C-$4.151.73%
2014C-$4.08-16.23%
2013C-$4.8791.67%
2012C-$2.54-31.45%
2011C-$3.71-27.06%
2010C-$5.08-43.75%
2009C-$9.03-57.33%
2008C-$21.18-82.92%
2007C-$123.9520.61%
2006C-$102.77175.76%
2005C-$37.27-21.43%
2004C-$47.43100%
2003C-$23.72-38.24%
2002C-$38.40161.54%
2001C-$14.68-106.46%
2000C$227.132051.55%
1999C$10.56839.73%
1998C$1.12-105.48%
1997C-$20.51-88.16%
1996C-$173.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
C-$1.74 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
C$0.49-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$14.13-5,368.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
C$0.56-310.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
C-$4.18 1,457.89%๐Ÿ‡บ๐Ÿ‡ธ USA